| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d667d655d078f7fd940f008043ccc62 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
2014-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e15ae16a2fb0fe766cceb0e8725033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89789fae8201f9e31eb4e63df676ddf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ebad5772e2092ebae13826a99fcf9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97ebc6ab7323a7d8fce31becded3a83d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1b4feba286243391c21affd691d7484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f368e2d8f13154f2a5737b707762ad2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdbaed59187e8ebdeb1fbc7086567b8e |
| publicationDate |
2015-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150106196-A |
| titleOfInvention |
A pharmaceutical composition for prevention or treatment of diabetes comprising n-(2-hydroxyethyl)-3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide or pharmaceutically acceptable salts thereof as an effective component |
| abstract |
The present invention relates to a pharmaceutical composition comprising N- (2-hydroxyethyl) -3- (6- (4- (trifluoromethoxy) phenylamino) pyrimidin-4-yl) benzamide or a pharmaceutically acceptable salt thereof, And to a health functional food and a pharmaceutical composition for preventing or treating diabetes. (2-hydroxyethyl) -3- (6- (4- (trifluoromethoxy) phenylamino) pyrimidin-4-yl) benzamide or a pharmaceutically acceptable salt thereof, Type 1 diabetes and type 2 diabetes, and the compound may also be used as a health functional food for preventing or ameliorating diabetes. |
| priorityDate |
2014-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |